SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2025 quarter moved down to Rs. 748.93 millions as compared to Rs. 890.58 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -103.28 millions as compared to Net Profit of Rs. 129.12 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -98.59% as compared to 200.12% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 748.93 890.58 -15.91 3457.68 3624.62 -4.61 3457.68 3624.62 -4.61
Other Income -51.14 104.43 -148.97 295.81 575.52 -48.60 295.81 575.52 -48.60
PBIDT -98.59 200.12 -149.27 326.07 1044.32 -68.78 326.07 1044.32 -68.78
Interest 1.32 0.68 94.12 4.10 3.21 27.73 4.10 3.21 27.73
PBDT -99.91 199.44 -150.10 321.97 1041.11 -69.07 321.97 1041.11 -69.07
Depreciation 18.18 18.30 -0.66 69.69 68.25 2.11 69.69 68.25 2.11
PBT -118.09 181.14 -165.19 252.28 972.86 -74.07 252.28 972.86 -74.07
TAX -14.81 52.02 -128.47 80.27 218.66 -63.29 80.27 218.66 -63.29
Deferred Tax -32.69 8.85 -469.38 21.03 42.76 -50.82 21.03 42.76 -50.82
PAT -103.28 129.12 -179.99 172.01 754.20 -77.19 172.01 754.20 -77.19
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) -13.16 22.47 -158.58 9.43 28.81 -67.27 9.43 28.81 -67.27

Albert David Share Price

800.00 0.90 (0.11%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×